Full Length Research Paper
References
|
Amed S, Oram R (2016). Maturity Onset Diabetes of the young (MODY): Making the right diagnosis to optimize treatment. Canada Journal of Diabetes 40:449-454. |
|
|
Bahnak BR, Gold AH (1982). Effects of alloxan diabetes on the turnover of rat liver glycogen synthase comparison with liver phosphorylase. Journal of Biological Chemistry 257:8775-8780. |
|
|
Cnop M, Welsh N, Jonas JC (2005). Mechanisms of pancreatic cell dealth in type 1 and type 2 diabetes. Journal of Diabetes 54:97-107. |
|
|
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014). Global Estimates of Diabetes Prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 103(2):137-149. |
|
|
Kameswara RB, Giri MM, Appa CH (1999). Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook fruit powder in alloxan-induced diabetic rats. Journal of Ethnopharmacology 67:103-109. |
|
|
Krishna B, Nammi S, Kofa MK, Kristina Rao RV (2004). Evaluation of hypoglycaemic and antihyperglycaemic effects of Datura metal Linn seeds in normal and alloxan- induced diabetic rats. Journal of Ethnopharmacology 91(1):95-98. |
|
|
Mironava MA, Klein R, Virella GT, Virella MF (2007). Antimodified LDL antibodies LDL- containing immune complexes and susceptible of LDL to in vitro oxidation in patients with type 2 diabetes. Journal of Diabetes 49:1033-104. |
|
|
Rother KI (2007). Diabetes treatment bridging the Divide. New England Journal of Medicine 356(15):1499-501. |
|
|
Sacks DB, Arnold M, Bakris GL (2011). Executive summary: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Journal Clinical Chemistry 57:793-798. |
|
|
Scoppola A, Montecci FR, Mezinger G, Lala A (2001). Urinary mevalonate excretion rate in type 2 diabetes: Role of metabolic control. Journal of Atherosclerosis 156(2001):357-361. |
|
|
Seuring T (2015). How Much Does Type 2 Diabetes Cost? PharmacoEconomics and Outcomes News 725(1):11-14. |
|
|
Shertzer HG, Woods SE, Krishan M (2011). Dietary when protein lowers the risk for metabolic disease in mice fed a high-fat diet. Journal of Nutrition 141:582-587. |
|
|
Tallroth GM, Lindgren G, Sternberg I, Agadh CD (1990). Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 diabetes mellitus and normal men. Diabetologia 33:319-327. |
|
|
Virella Lopes MF, Virella GT (2003). Processes in the development of macrovascular disease in diabetes. Frontiers in Bioscience 8:750-768. |
|
|
WHO Expert Committee on Diabetes mellitus (1980). Technical Report Series 646. World Health Organization, Geneva P 61. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
